Abzena, an integrated CDMO + CRO for complex biologics and bioconjugates, has named Taylor Boyd Chief Business Officer.  In this newly created role, Boyd will be responsible for corporate development, portfolio strategy, and partnering strategy activities to drive Abzena’s continued commitment to innovation and growth. Mr. Boyd has a strong track record of success within the life sciences and CDMO industry, primarily in strategic transactions and capital-raising activities. As CBO, he will pl...